Cost-effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis (IC) in Turkey

Anidulafungin has been shown to be non-inferior to, and possibly more efficacious, than fluconazole in treating patients with invasive candidiasis (IC). This study aimed to determine the cost-effectiveness of anidulafungin vs fluconazole for treatment of IC in the Turkish setting. A decision analyti...

Full description

Bibliographic Details
Published in:Mycoses
Main Author: Neoh C.F.; Senol E.; Kara A.; Dinleyici E.C.; Turner S.J.; Kong D.C.M.
Format: Article
Language:English
Published: Blackwell Publishing Ltd 2017
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85023160082&doi=10.1111%2fmyc.12651&partnerID=40&md5=16bbeb143ef3005883e393bae14d20d5

Similar Items